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Objectives To evaluate the clinical and laboratory findings of Streptococcus pneumoniae acute otitis media in
children during a 1 year period.
Methods From October 1995 to September 1996, 113 children aged 2 months to 14 years (median 18 months),
with S. pneumoniae acute otitis media were studied. Susceptibility testing was performed by the Kirby-Bauer
method and the E-test, and serotyping by the Quellung reaction.
Results E-test assays detected five isolates (4.4%) to be highly resistant to penicillin and 13 (11.5%) that had
intermediate resistance. All isolates were found to be susceptible to vancomycin, rifampicin and cefotaxime. In
total, 25 isolates (22.1%) were resistant to one or more drugs. Fifty per cent of the penicillin-resistant or
intermediately resistant S. pneumoniae isolates were resistant to multiple drugs, whereas only 2.1% of the
penicillin-susceptible isolates were resistant to multiple drugs. The predominating serogroups of the isolates
with reduced susceptibility to penicillin were the 19 (61.1%), 9 (16.7%), 23 (11.1%), 6 (5.5%) and 14 (5.5%)
whereas those of the susceptible isolates were the 19 (26.3%), 14 (13.7%), 3 (11.6%), 6 (11.6%), 9 (8.4%), 1
(5.3%) and 12 (5.3%).
Conclusions Streptococcus pneumoniae isolates from children with acute otitis media were penicillin-insensitive
in 15.9%. The multiresistant S. pneumoniae isolates belonged to serogroups: 19 (45.4%), 9 (27.3%), 6 (18.2%)
and 23 (9.1%).
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INTRODUCTION
Acute otitis media (AOM) is a very common pediatric disorder,
that more frequently affects the younger age groups. Streptococcus
pneumoniae is considered the most common cause of AOM,
followed by Haemophilus influenzae and Moraxella catarrhalis [1].
Pneumococcal otitis can be a serious disease leading to com-
plications in the central nervous system. An additional problem
is the difficulty in treatment that is a result of the increasing
world-wide incidence of resistance to penicillin [2–4], which
is generally considered as the antibiotic of first choice.
This study deals with the clinical and laboratory findings of
pneumococcal AOM in Greek children, during a 1 year period.
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MATERIALS AND METHODS
Study population
During a 1 year period (October 1995 to September 1996), a
total of 102 children examined in the outpatient department of
the childrens’ teaching hospital ‘P. and A. Kyriakou’ were
found to be suffering from pneumococcal AOM. An additional
11 children with the same infection that were hospitalized in
the above hospital were included in the study. The ages of the
children ranged from 2 months to 14 years, with a median of
18 months. The history, the clinical findings and the outcome
of the AOM were reviewed from the patients’ charts.
Microbiological studies
The specimens were taken by tympanocentesis in 29 cases
and in the remaining cases, which presented with tympanic
membrane perforation, the sampling was by alginate swabs. All
specimens were inoculated on blood, chocolate, MacConkey,
Chapman and Sabouraud agars, and into a brain heart infusion
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broth and incubated at 37 °C for up to 48 h. Blood agar and
chocolate agar plates were incubated in an atmosphere of 5%
CO2 for 24–72 h. Specimens were also plated onto a blood
agar with menadione and incubated anaerobically (Anaerobic
System, GasPak pouch; BBL, Becton Dickinson & Co, Cock-
eysville, MD, USA) for at least 5 days for the recovery of
anaerobic bacteria. The isolation and identification of the strains
were carried out by conventional methods, including Gram’s
stain, susceptibility to optochin and bile solubility. The anti-
biotic susceptibility testing was performed by the Kirby–Bauer
disc diffusion method on Mueller Hinton agar supplemented
with 5% blood. The inoculum was performed by direct colony
suspension in Mueller Hinton broth equivalent to a 0.5 McFar-
land turbidity standard. The concentrations of antimicrobial
agents in the discs used (Sanofi Diagnostic Pasteur, Sanofi Diag-
nostics Pasteur, Marnes-la-Coquette, France) were selected
according to NCCLS standards: cefaclor 30 mg, cefotaxime
30 mg, erythromycin 15 mg, trimethoprim/sulfamethoxazole
1.25/23.75 mg, clindamycin 2 mg, rifampicin 5 mg, tetracycline
30 mg, chloramphenicol 30 mg and vancomycin 30 mg. The
plates were incubated at 35 °C in 5% CO2 for 20–24 h. Peni-
cillin susceptibility was determined using 1 mg oxacillin disc
(Oxoid Ltd, Basingstoke, Hampshire, UK) and if the zone size
was 20 mm, the E-test (AB Biodisk, Solna, Sweden) was used
to determine the minimum inhibitory concentration (MIC),
according to the manufacturers’ guidelines. The breakpoints
for susceptibility, intermediate susceptibility and resistance
according to NCCLS standards were 0.06 mg/L, 0.1–
1.0 mg/L and 2 mg/L, respectively [5]. The S. pneumoniae
reference strain ATCC 49619 was included for quality control.
The serogrouping was performed by the capsular Quellung
reaction (Pneumotest, Seruminstitut Copenhagen).
Statistical analysis
The chi-squared test with Yates’ correction and Fisher’s exact
test were used where appropriate [6]. Differences with a P-
value of 0.05 were considered to be significant.
RESULTS
Streptococcus pneumoniae was isolated from the middle ear cultures
of 113 children, 51.3% males and 48.7% females. All patients
suffered from fever with temperature 38 °C, nervousness,
anorexia and otalgia. Middle-ear effusion was found in all chil-
dren and 84 children (74.3%) had otorrhoea. The infection was
unilateral in 89 children (78.8%) and bilateral in 24 (21.2%).
Only two (1.8%) of the children had received a beta-lactam
antibiotic in the preceding month. Streptococcus pneumoniae was
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the only pathogen in 69.9% of the cases and it was isolated in
mixed culture with one or two other pathogens in 30.1%. The
more common coexisting pathogens were H. influenzae (22
cases) and Staphylococcus aureus (13 cases).
Table 1 summarizes the resistance to antibiotics. Overall, 18
strains of S. pneumoniae were found to be penicillin-insensitive;
13 of these were intermediately resistant and five were highly
resistant to penicillin, as assayed by the E-test. For these latter
strains the penicillin MICs ranged from 2 to 3 mg/L. Thirteen
of the above isolates (72.2%) were recovered from children
under 18 months of age. Streptococcus pneumoniae isolates with
high or intermediate resistance to penicillin were found in 10
(17.2%) of the boys and in eight (14.5%) of the girls. The
difference was not statistically significant (x2 = 0.018,
P  0.05).
The distribution of serogroups as related to the susceptibility
status showed that the predominating serogroups among the
isolates with reduced susceptibility to penicillin were the 19
(61.1%), 9 (16.7%), 23 (11.1%), 6 (5.5%) and 14 (5.5%) whereas
those of the susceptible isolates were the 19 (26.3%), 14 (13.7%),
3 (11.6%), 6 (11.6%), 9 (8.4%), 1 (5.3%) and 12 (5.3%). Inter-
estingly, all isolates with high resistance to penicillin belonged
to serogroup 19. Table 2 presents the antibiotic resistance pat-
terns and serogroup distribution of the isolates. In total, 25
isolates (22.1%) were resistant to one or more drugs. Fifteen
different patterns of resistance were found: 8% of the isolates
were resistant to a single drug, 4.4% were resistant to two drugs,
3.5% to three, 3.5% to four and 2.6% to five. Of the penicillin-
resistant or intermediately resistant S. pneumoniae isolates 50%
(nine of 18) were resistant to three or more drugs of distinct
classes, whereas the corresponding figure for the penicillin-
susceptible isolates was only 2.1% (two of 95). This difference
was statistically significant (P  0.001). The multiresistant S.
pneumoniae isolates belonged to serogroups: 19 (45.4%), 9
(27.3%), 6 (18.2%) and 23 (9.1%).
The observed complications were tympanic membrane per-
foration in 84 children (74.3%), mastoiditis in four (3.5%), facial
nerve paralysis in one (0.9%) and bacteraemia and septic arthritis
in two (1.8%). The susceptibility of S. pneumoniae isolates to
penicillin was not proved to be a statistically significant factor
affecting the frequency of complications or the need for hos-
pitalization as was shown by the P-values from Fisher’s exact
test (P  0.05).
The initial antibiotic therapy for AOM was amoxicillin
40 mg/kg per day, given orally in three divided doses for 10
days. The clinical and bacteriological response to amoxicillin
treatment was successful in all children with penicillin-sensitive
S. pneumoniae AOM. The patients with AOM caused by peni-
cillin-insensitive S. pneumoniae were first treated with amox-
icillin and then changed to cefotaxime (100 mg/kg per day,
given intravenously in three divided doses for 7 days) when
laboratory results were available. There were no failures.
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Table 1 Antibiotic resistance of
113 S. pneumoniae
isolates from children with
AOM
Number (%) of isolates
Antibiotic Intermediately resistant Highly resistant
Oxacillin 18 (15.9)
Penicillin* 13 (11.5) 5 (4.4)
Cefaclor 2 (1.8) 6 (5.3)
Cefotaxime 0 (0.0)
Erythromycin 11 (9.7)
Trimethoprim/sulfamethoxazole 10 (8.8)
Clindamycin 4 (3.5)
Rifampicin 0 (0.0)
Tetracycline 9 (8.0)
Chloramphenicol 2 (1.8)
Vanomycin 0 (0.0)
*MIC ranges to penicillin: intermediately resistant 0.1–1.0 mg/L and highly resistant 2–3 mg/L.
Table 2 Antibiotic resistance
patterns and serogroup
distribution of 113
S. pneumoniae isolates from
children with acute otitis
media
Number of strains within the serogroups
Resistance phenotype* 6 9 14 19 23 Other Total (%)
S 9 8 11 22 3 35 88 (77.9)
P 4 1 5 (4.4)
E 2 2 (1.8)
TS 1 1 (0.9)
T 1 1 (0.9)
P/T 1 2 3 (2.7)
P/TS 1 1 (0.9)
E/C 1 1 (0.9)
P/TS/CEC 1 1 (0.9)
P/E/CEC 3 3 (2.7)
P/E/T/CEC 2 2 (1.8)
TS/T/E/CL 1 1 (0.9)
P/TS/E/CEC 1 1 (0.9)
P/CL/E/TS/T 1 1 (0.9)
C/T/CL/E/TS 1 1 (0.9)
P/CEC/CL/TS/E 1 1 (0.9)
*S, susceptible to all antibiotics tested.
P, penicillin (including intermediate and resistant strains); E, erythromycin; T, tetracycline; C,
chloramphenicol; CEC, cefaclor; CL, clindamycin; TS, trimethoprim/sulfamethoxazole.
DISCUSSION
The clinical diagnosis was made easily during our study from
the typical signs and symptoms in all cases. The incidence of
unilateral infection was similar, but the proportion of mixed
infection was found relatively high in comparison with other
reports [7].
The complications of AOM caused by S. pneumoniae and
other pathogens are usually very serious [8]. Fortunately in
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our study, the complications were rare, except for tympanic
membrane perforation. The complications were not correlated
significantly with the penicillin-susceptibility of the isolates,
although complications due to penicillin-resistant isolates
should be seriously considered, in every case of persistence of
symptoms after a few days of therapy [4].
Penicillin-resistant pneumococci have emerged throughout
the world in recent years. In USA a 60-fold increase from 1987
to 1992 was reported, but the resistance rates show strong
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geographical differences between the various states [3]. Euro-
pean data from different clinical sources, show major variations
between countries, from 4% in Belgium [9] to 44% in Spain
[10]. In Greece 14% was reported from adults with community-
acquired pneumonia which included highly and intermediately
resistant strains [11]. In our hospital, the overall incidence of
highly resistant and of intermediately resistant isolates from
different clinical sources, is 3.9% and 17.6%, respectively [12].
Of the S. pneumoniae isolates from carriers attending day-care
centres in south-western Greece, 17% were intermediate and
12% resistant to penicillin [13].
The isolates from AOM cases are usually less susceptible than
those from other sources. In recent studies, the rates of resistance
or reduced susceptibility to antibiotic of the isolates from AOM
ranged from 21 [7] to 31% [14,15] in various states of North
America. Our study showed a total reduced susceptibility in
15.9% of S. pneumoniae AOM isolates. Most children with these
isolates were under 18-months of age, confirming the findings
of other studies [14,16,17].
Antibiotics, other than penicillin or amoxicillin, have con-
siderable use in the therapy of AOM. Thus the resistance rates
must be reviewed frequently especially for pneumococcus. In
United States the overall resistance rates to cefotaxime, ery-
thromycin, trimethoprim/sulfamethoxazole and chlo-
ramphenicol were 9, 7–21, 26–43 and 24%, respectively [2]. In
Spain the percentages of resistance were 56% to tetracycline,
43% to chloramphenicol and 5% to erythromycin, summarizing
data from a 10 year period [10]. In Greece the rates for isolates
from adult patients with pneumonia in 1994, were 20% to
erythromycin, 26% to tetracycline and only 1% to chlo-
ramphenicol [11]. It was demonstrated also in the above studies,
that the penicillin-resistant isolates of pneumococci showed
significantly higher resistance rates to many agents other than
the sensitive ones [10,11]. Analogous results concerning
especially multiresistant S. pneumoniae isolates from AOM have
also been reported [14,18].
In our study, the percentages of resistance to antibiotics
except penicillin were lower than those mentioned above and
there was no resistance at all to cefotaxime, rifampicin and
vancomycin. The multiresistance among intermediately and
highly penicillin-resistant strains (50%) was significantly higher
than among penicillin-susceptible strains (2.1%).The sero-
groups of multiresistant S. pneumoniae strains were the 19, 9, 6
and 23 in decreasing order of frequency. The same serogroups
were distributed among the susceptible isolates. However the
higher proportion of serogroup 19 among isolates that were
intermediately resistant to penicillin and its exclusive rep-
resentation of the high penicillin-resistant isolates is of special
interest.
In Greek children AOM is often associated with penicillin-
resistant S. pneumoniae. Thus it is obviously important to collect
and test all isolates for penicillin resistance by 1 mg oxacillin
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disc and subsequently by MIC. An increase in the dosage of
amoxicillin is being considered for patients suffering from S.
pneumoniae strains that are intermediately resistant to penicillin.
However, all cases that are due to S. pneumoniae strains that
are highly resistant to penicillin should be treated with third
generation cephalosporins with ceftriaxone as the preferred
agent among them.
There were no differences in response in cases of infection
by S. pneumoniae alone when compared with mixed infections.
All isolates from the children of our study belonged to sero-
groups that were included in the commercially available poly-
saccharide vaccine but it cannot protect children under 2 years
of age and those that are immunocompromised.
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